Monksdream
10 months ago
Print
Share On Facebook
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (βClever Leavesβ or the βCompanyβ), a global medicinal cannabis company, today announced that its Board of Directors (the βBoardβ) determined to voluntarily delist its common shares, without par value (the βcommon sharesβ) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the βWarrantsβ and together with the common shares, the βSecuritiesβ) from The Nasdaq Stock Market LLC (βNasdaqβ) and deregister its Securities in order to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934, as amended (the βExchange Actβ).
The Company today notified Nasdaq of its intention to voluntarily delist its Securities from Nasdaq. The Company intends to file a Form 25 with the Securities and Exchange Commission (βSECβ) to effect the delisting and deregistration of its Securities on or about May 6, 2024 to effect the delisting from Nasdaq and the deregistration of the Securities under Section 12(b) of the Exchange Act. As a result, the Company expects the last day of trading of its Securities on Nasdaq will be on or about May 16, 2024.
kahlua
1 year ago
There has been extreme selling volume since the reverse split (daily volume by price chart says it all). Good old shady as hell Canaccord, CLVRβs sales agent for the at-the-market offering, has apparently tagged in the shorts/mmβs to dump into the bid with impunity and cover with the cheaper ATM shares. Until regulators step in and stick Canaccord and similar players with huge punitive fines, instead of tiny slap on wrist $100k fines, these games will never stop to the complete dismay of most retail investors. From the volume chart, I am estimating about 700K shares have been shorted or sold via the ATM since the share reversal. Letβs see where the stock trades once the dust settles and that should give us a clue of how much dilution is currently occurring. Based on my calculations using the latest cash position (7.8M) + estimated remaining Portugal assets to be sold ($1.5M) confirmed 2023 revenue and ebitda guidance and ongoing opex, I suspect they need another $3 - $4.5M to shore up all liquidity needs through Q2 2024. With that in mind, I am going way out on a limb and guessing we are going to see the share count go from 1.5M to 2.5 or even 3M in the near term, meaning significant dilution, which they were incapable of orchestrating prior to this r/s. Been watching this stock unravel since the ipo and unfortunately still holding some virtually worthless warrants.